Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04849897 · ClinicalTrials.gov registry record · NA

Virtual Reality Guided Imagery for Chronic Pain

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT04849897: Completed NA study, sponsored by University of Southern California.

NCT04849897 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04849897, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

To assess treatment with an at-home Virtual Reality Guided Imagery (VR-GI) intervention, 36 patients with chronic pain (18 with chronic back pain, CBP, and 18 with complex regional pain syndrome, CRPS) will complete a 2-week intervention with at-home daily practice of VR-GI (n = 24) or audio-only GI (n = 12). Pre-post treatment measures of pain intensity, opioid use, functional outcomes, and mood will be collected. Intervention feasibility and patient satisfaction will be evaluated post-treatment via questionnaire and qualitative interview.

Primary Outcome

Participant log tracks number of recruited participants who are ineligible to participate and/or decline to enroll

Interventions

  • DEVICE Experimental: Virtual Reality Guided Imagery
  • OTHER Active Comparator: Audio Only Guided Imagery

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-03-22
Est. Completion 2022-04-30
Phase NA
University of Southern California

617 total trials

What the finished NCT04849897 record still lists

NCT04849897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Experimental: Virtual Reality Guided Imagery is the first listed.

NCT04849897 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04849897 about?

NCT04849897 is a clinical study titled "Virtual Reality Guided Imagery for Chronic Pain". To assess treatment with an at-home Virtual Reality Guided Imagery (VR-GI) intervention, 36 patients with chronic pain (18 with chronic back pain, CBP, and 18 with complex regional pain syndrome, CRPS) will complete a 2-week intervention with at-home daily practice of VR-GI (n = 24) or audio-only GI...

What is the current status of trial NCT04849897?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-03-22. Estimated completion is 2022-04-30.

What interventions are being tested in trial NCT04849897?

The interventions under investigation include: Experimental: Virtual Reality Guided Imagery (DEVICE), Active Comparator: Audio Only Guided Imagery (OTHER).

Who is sponsoring clinical trial NCT04849897?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04849897's enrollment target sits among peer trials

36 1541st of 2000 higher than 437 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04849897, the US trial registry maintained by the National Library of Medicine. NCT04849897 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.